^
7ms
TSN222 in Subjects With Advanced Solid Tumors or Lymphomas (clinicaltrials.gov)
P1/2, N=162, Recruiting, Tyligand Bioscience (Shanghai) Limited | Not yet recruiting --> Recruiting
Enrollment open • Metastases
|
BRAF (B-raf proto-oncogene)
|
BRAF mutation
|
TSN222
over1year
TSN222 in Subjects With Advanced Solid Tumors or Lymphomas (clinicaltrials.gov)
P1/2, N=162, Not yet recruiting, Tyligand Bioscience (Shanghai) Limited
New P1/2 trial
|
BRAF (B-raf proto-oncogene)
|
BRAF mutation
|
TSN222